Increased plasma phosphatidylcholine/lysophosphatidylcholine ratios in patients with Parkinson's disease.
Jadranka Miletić VukajlovićDunja DrakulićSnežana PejićTihomir V IlićAleksandra StefanovićMarijana PetkovićJürgen SchillerPublished in: Rapid communications in mass spectrometry : RCM (2020)
To our knowledge, this is the first study examining the PC/LPC ratios in plasma of patients with PD and illustrating their correlation with clinico-pathological features. Although the presented results may be considered as preliminary due to the limited number of participants, the observed alterations of PC/LPC ratios in plasma might be a first step in the characterization of plasma lipid changes in PD patients and an indicator of lipid reconfiguration.